View |
|
DR-XY42086
|
Zinc (as Zinc gluconate)
|
None
|
10 mg
|
Chewable Tablet
|
Minerals
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
12 June 2023
|
06 June 2028
|
View |
DR-XY42092_PI_01.pdf
|
DR-XY42092
|
Rosuvastatin (as calcium)
|
Zenrosu
|
20mg
|
Film-Coated Tablet
|
-
|
Zentiva, k.s.
|
Czech Republic
|
Automatic Renewal
|
23 June 2021
|
05 June 2026
|
View |
|
DR-XY42095
|
Cefuroxime (as axetil)
|
Uroxime-500
|
500mg
|
Tablet
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
Umedica Laboratories Pvt. Ltd.
|
India
|
Automatic Renewal
|
20 July 2023
|
13 June 2028
|
View |
|
DR-XY42110
|
Piracetam
|
Neurocetam
|
1200 mg
|
Tablet
|
Psychoanaleptic ( Other Psychostimulant and Nootropic)
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
13 March 2023
|
13 June 2028
|
View |
DR-XY42115_PI_01.pdf
|
DR-XY42115
|
Lapatinib (As Ditosylate)
|
Tykerb
|
250 mg
|
Film-Coated Tablet
|
-
|
Glaxo Operations UK Limited Trading as Glaxo Wellcome Operations
|
United Kingdom
|
-
|
29 July 2020
|
13 June 2025
|
View |
|
DR-XY42119
|
Lidocaine Hydrochloride
|
Xylocare
|
20mg/mL(2%)
|
Solution For Injection
|
Local Anesthetic
|
Vesco Pharmaceutical Company Limited
|
Thailand
|
Automatic Renewal
|
08 May 2023
|
14 June 2028
|
View |
|
DR-XY42125
|
Ciprofloxacin (as hydrochlride)
|
Aciprex
|
3 mg/mL (0.3% w/v)
|
Ophthalmic Solution (Drops)
|
Antibacterials (Fluoroquinolones)
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
19 May 2023
|
17 June 2028
|
View |
|
DR-XY42129
|
Verapamil hydrochloride
|
Verapril
|
40mg
|
Sugar Coated Tablet
|
Calcium Channel Blocker
|
Jiangsu Ruinian Qianjin Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
12 April 2023
|
18 June 2028
|
View |
|
DR-XY42133
|
Metformin Hydrochloride
|
Metoflex
|
500mg
|
Extended-Release Tablet
|
-
|
Shou Chan Industrial Co., Ltd.
|
China
|
-
|
03 August 2020
|
18 June 2025
|
View |
|
DR-XY42135
|
Piroxicam
|
Curadec
|
20 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID) (Oxicam)
|
McOlson Research Laboratories (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
21 June 2023
|
19 June 2028
|
View |
|
DR-XY42138
|
Ascorbic acid + Calcium + Cholecalciferol (Vitamin
D3)
|
Bewell-C Plus
|
Formulation: Each capsule contains: Ascorbic acid
(equivalent to Calcium Ascorbate 500 mg) - 206.548 Calcium
(equivalent to Calcium Citrate 500 mg)-35.125 mg Cholecalciferol (Vitamin D3) -200 IU
|
Capsule
|
-
|
Lejal Laboratories, Inc.
|
Philippines
|
-
|
26 February 2021
|
20 June 2026
|
View |
|
DR-XY42139
|
Tolnaftate
|
Healthcare Tinea
|
10mg/mL (1% w/v)
|
Topical Solution
|
Antifungals
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
02 March 2023
|
20 June 2028
|
View |
|
DR-XY42145
|
D-Alpha Tocopherol (Vitamin E)
|
FAIRY-E
|
400 IU
|
Softgel Capsule
|
VITAMIN
|
Northfield Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 June 2023
|
19 June 2028
|
View |
|
DR-XY42146
|
Beclometasone dipropionate + Formoterol fumarate
dihydrate
|
Foster
|
100 mcg + 6 mcg per actuation
|
Metered Dose Inhaler
|
Adrenergic-Corticosteroid Combination
|
Chiesi Farmaceutici S.p.A.
|
Italy
|
Initial (Variation) (Correction)
|
18 January 2024
|
12 October 2028
|
View |
|
DR-XY42147
|
Tafluprost
|
Taflotan
|
15 mcg/mL (0.0015%)
|
Ophthalmic Solution
|
Antiglaucoma preparations and Miotics
(Prostaglandin analogues)
|
Santen Pharmaceutical Co., Ltd.
|
Japan
|
Automatic Renewal
|
23 June 2021
|
25 June 2026
|
View |
|
DR-XY42149
|
Valsartan
|
Valsajub
|
160 mg
|
Film-Coated Tablet
|
Angiotensin-II-Receptor blocker
|
Jubilant Generics Limited
|
India
|
Renewal
|
21 March 2023
|
26 June 2028
|
View |
|
DR-XY42152
|
Valsartan
|
Valsajub
|
80 mg
|
Film-Coated Tablet
|
Angiotensin-II-Receptor blocker
|
Jubilant Generics Limited
|
India
|
Automatic Renewal
|
12 March 2023
|
26 June 2028
|
View |
|
DR-XY42155
|
Candesartan Cilexetil
|
Atasart
|
16mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
Automatic Renewal
|
02 February 2023
|
01 July 2028
|
View |
|
DR-XY42156
|
Candesartan Cilexetil
|
Atasart
|
8mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
Automatic Renewal
|
05 January 2023
|
01 July 2028
|
View |
|
DR-XY42158
|
Lornoxicam
|
Mosan
|
8mg
|
Lyophilized Powder For Injection
|
Non-steroidal Anti-inflammatory Drug (Oxicam)
|
Gufic Biosciences Ltd
|
India
|
Automatic Renewal
|
02 July 2023
|
25 June 2028
|